genworth financial inc. - GNW
GNW
Close Chg Chg %
7.41 -0.11 -1.49%
Closed Market
7.30
-0.11 (1.49%)
Volume: 4.88M
Last Updated:
Jul 11, 2025, 3:59 PM EDT
Company Overview: genworth financial inc. - GNW
GNW Key Data
| Open $7.32 | Day Range 7.26 - 7.37 |
| 52 Week Range 5.99 - 8.08 | Market Cap $3.07B |
| Shares Outstanding 414.46M | Public Float 405.29M |
| Beta 1.06 | Rev. Per Employee N/A |
| P/E Ratio 15.04 | EPS $0.50 |
| Yield 0.00% | Dividend $0.10 |
| EX-DIVIDEND DATE Oct 8, 2008 | SHORT INTEREST N/A |
| AVERAGE VOLUME 7.74M |
GNW Performance
| 1 Week | -8.76% | ||
| 1 Month | 4.89% | ||
| 3 Months | 11.47% | ||
| 1 Year | 17.77% | ||
| 5 Years | 248.80% |
GNW Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
2
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 9.00 | |
| Number of Ratings | 2 | Current Quarters Estimate | 0.105 | |
| FY Report Date | 09 / 2025 | Current Year's Estimate | 0.44 | |
| Last Quarter’s Earnings | 0.105 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.62 | Next Fiscal Year Estimate | 0.52 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 2 | 2 | 2 | 2 |
| Mean Estimate | 0.11 | 0.11 | 0.44 | 0.52 |
| High Estimates | 0.15 | 0.16 | 0.62 | 0.61 |
| Low Estimate | 0.06 | 0.06 | 0.26 | 0.43 |
| Coefficient of Variance | 60.61 | 64.28 | 57.85 | 24.48 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 1 | 1 | 0 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 1 | 1 | 2 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Hold |
SEC Filings for Genworth Financial Inc. - GNW
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Genworth Financial Inc. - GNW
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 3, 2025 | Gregory S. Karawan EVP and General Counsel | 75,949 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Andrea Lynn White Pres. & CEO, CareScout Ins. | 642,101 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.65 per share | 4,269,971.65 |
| Mar 3, 2025 | Andrea Lynn White Pres. & CEO, CareScout Ins. | 648,638 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2025 | Andrea Lynn White Pres. & CEO, CareScout Ins. | 43,432 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2025 | Andrea Lynn White Pres. & CEO, CareScout Ins. | 56,259 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Melissa Hagerman EVP and Chief HR Officer | 70,323 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Melissa Hagerman EVP and Chief HR Officer | 43,432 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2025 | Melissa Hagerman EVP and Chief HR Officer | 110,930 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.65 per share | 737,684.50 |
| Mar 3, 2025 | Melissa Hagerman EVP and Chief HR Officer | 117,467 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2025 | Mark Blakeley Hodges EVP and Chief Risk Officer | 88,804 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2025 | Mark Blakeley Hodges EVP and Chief Risk Officer | 43,432 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2025 | Jerome T. Upton EVP & Chief Financial Officer | 421,867 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2025 | Gregory S. Karawan EVP and General Counsel | 54,289 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2025 | Mark Blakeley Hodges EVP and Chief Risk Officer | 56,259 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Gregory S. Karawan EVP and General Counsel | 315,846 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.65 per share | 2,100,375.90 |
| Mar 3, 2025 | Gregory S. Karawan EVP and General Counsel | 323,379 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2025 | Mark Blakeley Hodges EVP and Chief Risk Officer | 82,267 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.65 per share | 547,075.55 |
| Mar 3, 2025 | Samir B Shah Pres. & CEO, CareScout Svcs. | 112,518 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Jerome T. Upton EVP & Chief Financial Officer | 112,518 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Jerome T. Upton EVP & Chief Financial Officer | 86,862 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |